Insights

Gathering insights about Atrium…

Similar companies to Atrium

Atrium Tech Stack

Atrium uses 8 technology products and services including html5media, Gearset, Informatica, and more. Explore Atrium's tech stack below.

html5media
Audio, Video, Graphics
Gearset
Deployment
Informatica
Enterprise
OpenAI
Generative Ai
Microsoft Azure
Platform As A Service
Hadoop
Programming Languages
R Project
Programming Languages
SOAP
Web & Portal Technology

Media & News

Atrium Therapeutics Reports First Quarter 2026 Financial Results
SAN DIEGO, May 14, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) ("Atrium," "Atrium Therapeutics" or the "Company"), a biopharmaceutical company advancing precision cardiology by developing RNA therapeutics targeted to the heart, today reported financial results for the first quarter ended March 31, 2026, and highlighted recent corporate progress following its launch as a public company. "Our focused pipeline, strong cash balance and experienced team are driving significant momentum as we build a dedicated precision cardiology company," said Kathleen Gallagher, President and Chief Executive Officer of Atrium Therapeutics.
May 14, 2026 | www.prnewswire.com
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
SAN DIEGO, April 23, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics directly to the heart, announced today it has earned a $15 million development milestone payment from Bristol Myers Squibb (NYSE: BMY). The milestone was achieved upon the successful delivery of a development candidate for the first licensed compound targeting a cardiology indication under the Company's ongoing collaboration.
Apr 23, 2026 | www.prnewswire.com
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on April 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as a material inducement to the employment of seven non-executive individuals newly hired by the Company. The employees received, in the aggregate, non-qualified stock options to purchase 101,250 shares of the Company's common stock, par value $0.001 per share, with an exercise price of $14.30 per share, the closing price of the Company's common stock as reported by Nasdaq on the effective date of the grant, 25% of which will vest and become exercisable on the first anniversary of the grant date, and the remaining underlying shares will vest in 36 substantially equal installments each month thereafter, subject to the employee's continued service with the Company through each applicable vesting date; and restricted stock units for an aggregate of 50,625 shares of the Company's common stock, 25% of which will vest in the first anniversary of the grant date, and the remaining underlying shares will vest in three substantially equal installments each year thereafter, subject to the employee's continued service with the Company through each applicable vesting date, or collectively, the "Awards.
Apr 20, 2026 | www.prnewswire.com
Avidity Biosciences (NASDAQ:RNA) Sets New 52-Week Low – Here’s Why
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) shares hit a new 52-week low on Saturday. The company traded as low as $13.06 and last traded at $14.75, with a volume of 7932167 shares changing hands. The stock had previously closed at $14.58. Analyst Ratings Changes A number of analysts have commented on RNA
Mar 02, 2026 | www.defenseworld.net
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
Spinoff from Novartis AG's acquisition of Avidity Biosciences advances precision cardiology programs using targeted RNA delivery platform Lead candidates ATR 1072 and ATR 1086 expected to enter clinical trials for PRKAG2 syndrome and PLN cardiomyopathy, respectively SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) launched today as a newly independent, publicly traded company dedicated to delivering RNA therapeutics directly to the heart to transform care for people living with rare, life-threatening genetic cardiomyopathies. Atrium Therapeutics was established in connection with Avidity Biosciences, Inc.'s acquisition by Novartis AG.
Feb 27, 2026 | www.prnewswire.com
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™) to profoundly improve people's lives, today announced that the company will be presenting one oral and six poster presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held March 8-11, 2026, in Orlando, Florida. 2026 MDA Clinical & Scientific Congress Presentations Oral Presentation: Del-zota Treatment is Associated with Near Normalization of CK Levels and Improvements in Key Functional Outcomes at 1 Year in Participants with DMD44 (March 11, 2026: 12:30 p.m.
Feb 26, 2026 | www.prnewswire.com
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (NASDAQ: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ("AOCs™") to profoundly improve people's lives, today announced that it intends to convene its upcoming special meeting of stockholders (the "Special Meeting") scheduled for February 23, 2026, at 10:00 a.m., Eastern time, and then immediately adjourn proceedings, without conducting any other business.
Feb 23, 2026 | www.prnewswire.com

Atrium's Email Address Formats

Atrium uses at least 1 format(s):

Atrium Email Formats	Example	Percentage
First.Last@atrium.ai	John.Doe@atrium.ai	64%
First@atrium.ai	John@atrium.ai	23%
FLast@atrium.ai	JDoe@atrium.ai	12%
Last@atrium.ai	Doe@atrium.ai	1%

Frequently Asked Questions

Where is Atrium's headquarters located?

Atrium's main headquarters is located at 4055 Valley Commons Drive Bozeman, Montana 59718 United States. The company has employees across 6 continents, including North AmericaAsiaSouth America.

What is Atrium's stock symbol?

Atrium is a publicly traded company; the company's stock symbol is RNA.

What is Atrium's official website and social media links?

Atrium's official website is atrium.ai and has social profiles on LinkedIn.

What is Atrium's NAICS code?

Atrium's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Atrium have currently?

As of May 2026, Atrium has approximately 322 employees across 6 continents, including North AmericaAsiaSouth America. Key team members include Vp Of Marketing & Alliances: N. M.Vp Customer Engagement: B. L.Vice President Of Revenue Management: S. H. B.. Explore Atrium's employee directory with LeadIQ.

What industry does Atrium belong to?

Atrium operates in the IT Services and IT Consulting industry.

What technology does Atrium use?

Atrium's tech stack includes html5mediaGearsetInformaticaOpenAIMicrosoft AzureHadoopR ProjectSOAP.

What is Atrium's email format?

Atrium's email format typically follows the pattern of First.Last@atrium.ai. Find more Atrium email formats with LeadIQ.

When was Atrium founded?

Atrium was founded in 2018.

Atrium

Q: What is Atrium's official website and social media links?

Atrium's official website is atrium.ai. Atrium has social profiles on LinkedIn.

Q: How many employees does Atrium have currently?

Atrium has approximately 322 employees.

Q: What technology does Atrium use?

Atrium's tech stack includes LinkedIn, React, Qualified, Slick, PHP.

Q: What is Atrium's NAICS code?

Atrium's NAICS code is 5415 (Computer Systems Design and Related Services).

IT Services and IT ConsultingMontana, United States201-500 Employees

Atrium is the leading consulting firm in the Snowflake and Salesforce ecosystems at leveraging AI to deliver business outcomes.

Since launching in 2018, we’ve built deep expertise in data science, enterprise technology, and cloud transformation. From our earliest days deploying simple lead scoring models to building custom AI agents like Andi, we’ve been driven by one vision: redefining AI consulting through solutions that deliver measurable impact.

Company Overview

Headquarters: 4055 Valley Commons Drive Bozeman, Montana 59718 United States
Website: atrium.ai
Stock Symbol: RNA
NAICS Code: 5415 - Computer Systems Design and Related Services
Founded: 2018
Employees: 201-500

Media & News

Funding & Financials

$100M$250M
Atrium's revenue is estimated to be in the range of $100M$250M

Funding & Financials

$100M$250M
Atrium's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Atrium

Docusign

LegalZoom

Rocket Lawyer

Actionstep

MyCase

Bill4Time

LawDepot

PracticePanther

Rocket Matter

Atrium Tech Stack

Media & News

Atrium Therapeutics Reports First Quarter 2026 Financial Results

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Avidity Biosciences (NASDAQ:RNA) Sets New 52-Week Low – Here’s Why

Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders

Atrium's Email Address Formats

Frequently Asked Questions

Where is Atrium's headquarters located?

What is Atrium's stock symbol?

What is Atrium's official website and social media links?

What is Atrium's NAICS code?

How many employees does Atrium have currently?

What industry does Atrium belong to?

What technology does Atrium use?

What is Atrium's email format?

When was Atrium founded?

Atrium

Company Overview

Media & News

Atrium Therapeutics Reports First Quarter 2026 Financial Results

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?